• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
EKSO

EKSO

Ekso Bionics Holdings, Inc.

NASDAQHealthcareMedical - Instruments & SuppliesUS

USD11.80

+0.15 (+1.29%)

Company Profile

CEO

Scott G. Davis

IPO Date

2014-01-17

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Exchange

NASDAQ

Country

US

Market Metrics

Open

$11.40

Prev. Close

$11.65

Day Low

$11.40

Day High

$11.80

52W Low

$2.73

52W High

$13.50

Market Cap

$0.03B

Volume

0.10M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

30.6%

Avg Negative

13.1%

Avg Neutral

56.0%

News Feed

Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/29/2021·↓ negative

Ekso Bionics Reports Second Quarter 2021 Results

GlobeNewsWire·7/29/2021·↑ positive

Moving Average Crossover Alert: Ekso Bionics (EKSO)

Zacks Investment Research·5/13/2021·↓ negative

Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·4/29/2021·↓ negative

Ekso Bionics Holdings: Q1 Earnings Insights

Benzinga·4/29/2021·↑ positive

Ekso Bionics Reports First Quarter 2021 Results

GlobeNewsWire·4/29/2021·↑ positive

Will Ekso Bionics (EKSO) Report Negative Q1 Earnings? What You Should Know

Zacks Investment Research·4/22/2021·↑ positive

Ekso Bionics (EKSO) Surges 9.4%: Is This an Indication of Further Gains?

Zacks Investment Research·4/12/2021·↑ positive

Ekso Bionics Announces Partnership with U.S. Physiatry to Support Physician Education of EksoNR

GlobeNewsWire·3/9/2021·↑ positive

Ekso Bionics' (EKSO) CEO Jack Peurach on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·2/25/2021·↓ negative